UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | V | W | Y
Number of items: 175.

A

A'Hern, RP; Jamal-Hanjani, M; Szasz, AM; Johnston, SRD; Reis-Filho, JS; Roylance, R; Swanton, C; (2013) Taxane benefit in breast cancer-a role for grade and chromosomal stability. NATURE REVIEWS CLINICAL ONCOLOGY , 10 (6) pp. 357-364. 10.1038/nrclinonc.2013.67.

Adelman, CA; Lolo, RL; Birkbak, NJ; Murina, O; Matsuzaki, K; Horejsi, Z; Parmar, K; ... Boulton, SJ; + view all (2013) HELQ promotes RAD51 paralogue-dependent repair to avert germ cell loss and tumorigenesis. NATURE , 502 (7471) 381-+. 10.1038/nature12565.

Aksoy, E; Taboubi, S; Torres, D; Delbauve, S; Hachani, A; Whitehead, MA; Pearce, WP; ... Vanhaesebroeck, B; + view all (2013) The p110 delta isoform of the kinase PI(3)K controls the subcellular compartmentalization of TLR4 signaling and protects from endotoxic shock (vol 13, pg 1045, 2012). NATURE IMMUNOLOGY , 14 (8) p. 877. 10.1038/ni0813-877d.

Almagro, JC; Gilliland, GL; Scott, J; Larrick, JW; Plueckthun, A; Veldman, T; Adams, GP; ... Huston, JS; + view all (2013) Antibody Engineering and Therapeutics Conference The Annual Meeting of the Antibody Society, December 8-12, 2013, Huntington Beach, CA. MABS , 5 (6) pp. 817-825. 10.4161/mabs.26545.

Alrifai, D; Popat, S; Ahmed, M; Gonzalez, D; Nicholson, AG; du Parcq, J; Benepal, T; (2013) A rare case of squamous cell carcinoma of the lung harbouring ALK and BRAF activating mutations. LUNG CANCER , 80 (3) pp. 339-340. 10.1016/j.lungcan.2013.02.002.

Altobelli, G; Bogdarina, IG; Stupka, E; Clark, AJL; Langley-Evans, S; (2013) Genome-Wide Methylation and Gene Expression Changes in Newborn Rats following Maternal Protein Restriction and Reversal by Folic Acid. PLOS ONE , 8 (12) 10.1371/journal.pone.0082989. Gold open access

Amin, J; Chuckowree, I; Tizzard, GJ; Coles, SJ; Wang, M; Bingham, JP; Hartley, JA; (2013) Targeting Epidermal Growth Factor Receptor with Ferrocene-Based Kinase Inhibitors. ORGANOMETALLICS , 32 (2) pp. 509-513. 10.1021/om300974d.

Astin, R; Bentham, R; Djafarzadeh, S; Horscroft, JA; Kuc, RE; Leung, PS; Skipworth, JRA; ... Szabadkai, G; + view all (2013) No evidence for a local renin-angiotensin system in liver mitochondria. SCIENTIFIC REPORTS , 3 (ARTN 246) 10.1038/srep02467.

Azim, HA; Michiels, S; Zagouri, F; Delaloge, S; Filipits, M; Namer, M; Neven, P; ... Swanton, C; + view all (2013) Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement. ANNALS OF ONCOLOGY , 24 (3) pp. 647-654. 10.1093/annonc/mds645.

B

Baird, RD; Cresti, N; Beddowes, E; Saggese, M; Flynn, M; Corbacho, JG; Gao, F; ... Spicer, J; + view all (2013) Phase I trial of S-222611, a dual tyrosine kinase inhibitor of EGFR and HER2, with preliminary evidence of efficacy in patients (pts) with heavily-pretreated HER2-positive metastatic breast cancer. Presented at: UNSPECIFIED.

Bartlett, J; Canney, P; Campbell, A; Cameron, D; Donovan, J; Dunn, J; Earl, H; ... Stein, R; + view all (2013) Selecting Breast Cancer Patients for Chemotherapy: The Opening of the UK OPTIMA Trial. CLINICAL ONCOLOGY , 25 (2) pp. 109-116. 10.1016/j.clon.2012.10.005.

Bhosle, J; Kiakos, K; Porter, ACG; Wu, J; Makris, A; Hartley, JA; Hochhauser, D; (2013) Treatment with Gefitinib or Lapatinib Induces Drug Resistance through Downregulation of Topoisomerase II alpha Expression. MOLECULAR CANCER THERAPEUTICS , 12 (12) pp. 2897-2908. 10.1158/1535-7163.MCT-12-1049.

Bielack, SS; Smeland, S; Whelan, J; Marina, N; Hook, J; Jovic, G; Krailo, MD; ... Bernstein, ML; + view all (2013) MAP plus maintenance pegylated interferon alpha-2b (MAP-IFN) versus MAP alone in patients (pts) with resectable high-grade osteosarcoma and good histologic response to preoperative MAP: First results of the EURAMOS-1 good response randomization. Journal of Clinical Oncology , 31 (15) 10.1200/JCO.2014.60.0734. Green open access
file

Bielack, SS; Smeland, S; Whelan, J; Marina, N; Hook, J; Jovic, G; Krailo, MD; ... Bernstein, ML; + view all (2013) MAP plus maintenance pegylated interferon alpha-2b (MAPIfn) versus MAP alone in patients with resectable high-grade osteosarcoma and good histologic response to preoperative MAP: First results of the EURAMOS-1 "good response" randomization. In: (Proceedings) 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO). AMER SOC CLINICAL ONCOLOGY

Bridgewater, J; Palmer, D; Cunningham, D; Iveson, T; Gillmore, R; Waters, J; Harrison, M; ... Valle, J; + view all (2013) Outcome of second-line chemotherapy for biliary tract cancer. EUROPEAN JOURNAL OF CANCER , 49 (6) p. 1511. 10.1016/j.ejca.2012.11.024.

Brucoli, F; Hawkins, RM; James, CH; Jackson, PJM; Wells, G; Jenkins, TC; Ellis, T; ... Thurston, DE; + view all (2013) An Extended Pyrrolobenzodiazepine-Polyamide Conjugate with Selectivity for a DNA Sequence Containing the ICB2 Transcription Factor Binding Site. JOURNAL OF MEDICINAL CHEMISTRY , 56 (16) pp. 6339-6351. 10.1021/jm4001852.

Brunetto, AT; Ang, JE; Lal, R; Olmos, D; Molife, LR; Kristeleit, R; Parker, A; ... De Bono, J; + view all (2013) First-in-human, pharmacokinetic and pharmacodynamic phase I study of Resminostat, an oral histone deacetylase inhibitor, in patients with advanced solid tumors. Clin Cancer Res , 19 (19) pp. 5494-5504. 10.1158/1078-0432.CCR-13-0735.

Burrell, RA; McClelland, SE; Endesfelder, D; Groth, P; Weller, M-C; Shaikh, N; Domingo, E; ... Swanton, C; + view all (2013) Replication stress links structural and numerical cancer chromosomal instability (vol 494, pg 492, 2013). NATURE , 500 (7463) p. 490. 10.1038/nature12369.

Burrell, RA; McClelland, SE; Endesfelder, D; Groth, P; Weller, M-C; Shaikh, N; Domingo, E; ... Swanton, C; + view all (2013) Replication stress links structural and numerical cancer chromosomal instability. NATURE , 494 (7438) pp. 492-496. 10.1038/nature11935.

Burrell, RA; McGranahan, N; Bartek, J; Swanton, C; (2013) The causes and consequences of genetic heterogeneity in cancer evolution. NATURE , 501 (7467) pp. 338-345. 10.1038/nature12625.

Butt, MA; Oukrif, D; Haidry, RJ; Rashid, M; Khan, S-U-R; Pye, H; Bloom, ES; ... Lovat, LB; + view all (2013) CHARACTERISATION OF OESOPHAGEAL MUC1 EXPRESSION IN THE PROGRESSION TO OESOPHAGEAL ADENOCARCINOMA. In: (Proceedings) Annual General Meeting of the British-Society-of-Gastroenterology. (pp. A113-A114). BMJ PUBLISHING GROUP

C

Calvert, AH; Gonzalez, M; Ganguli, S; Ng, M; Benafif, S; Capelan, M; Goldstein, R; ... Kristeleit, R; + view all (2013) A first-in-human (FIH) dose-escalation study of the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of intravenous BAL101553, a novel microtubule inhibitor, in adult patients with advanced solid tumors. In: (Proceedings) 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO). AMER SOC CLINICAL ONCOLOGY

Calvert, AH; Gonzalez, M; Ganguli, S; Ng, M; Benafif, S; Capelan, M; Goldstein, R; ... Kristeleit, RS; + view all (2013) A first-in-human (FIH) dose-escalation study of the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of intravenous BAL101553, a novel microtubule inhibitor, in adult patients with advanced solid tumors. In: American Society of Clinical Oncology: JCO

Calvo, E; Forster, M; Szyldergemajn, S; Boni, V; Benafif, S; Kahatt, C; Turnbull, S; ... Soto Matos-Pita, A; + view all (2013) Lurbinectedin (PM01183) in combination with doxgrubicin (DOX): Preliminary results of a phase Ib study. In: (Proceedings) European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO. (pp. S178-S179). ELSEVIER SCI LTD

Caplin, B; Veighey, K; Mahenderan, A; Manook, M; Henry, J; Nitsch, D; Harber, M; ... Veitch, P; + view all (2013) Early changes in scores of chronic damage on transplant kidney protocol biopsies reflect donor characteristics, but not future graft function. Clin Transplant , 27 (6) E669-E678. 10.1111/ctr.12251. Green open access
file

Carpentier, S; N'Kuli, F; Grieco, G; Van der Smissen, P; Janssens, V; Emonard, H; Bilanges, B; ... Courtoy, PJ; + view all (2013) Class III Phosphoinositide 3-Kinase/VPS34 and Dynamin are Critical for Apical Endocytic Recycling. TRAFFIC , 14 (8) pp. 933-948. 10.1111/tra.12079.

Casado, P; Alcolea, MP; Iorio, F; Rodriguez-Prados, J-C; Vanhaesebroeck, B; Saez-Rodriguez, J; Joel, S; (2013) Phosphoproteomics data classify hematological cancer cell lines according to tumor type and sensitivity to kinase inhibitors. GENOME BIOLOGY , 14 (4) 10.1186/gb-2013-14-4-r37.

Casado, P; Rodriguez-Prados, J-C; Cosulich, SC; Guichard, S; Vanhaesebroeck, B; Joel, S; Cutillas, PR; (2013) Kinase-Substrate Enrichment Analysis Provides Insights into the Heterogeneity of Signaling Pathway Activation in Leukemia Cells. SCIENCE SIGNALING , 6 (268) 10.1126/scisignal.2003573.

Castañeda, L; Maruani, A; Schumacher, FF; Miranda, E; Chudasama, V; Chester, KA; Baker, JR; ... Caddick, S; + view all (2013) Acid-cleavable thiomaleamic acid linker for homogeneous antibody-drug conjugation. Chemical Communications , 49 pp. 8187-8189. 10.1039/c3cc45220d. Green open access
filefile

Chang, J; Nicolau, MM; Cox, TR; Wetterskog, D; Martens, JWM; Barker, HE; Erler, JT; (2013) LOXL2 induces aberrant acinar morphogenesis via ErbB2 signaling. BREAST CANCER RESEARCH , 15 (4) 10.1186/bcr3461.

Chavda, S; Babu, B; Patil, P; Plaunt, A; Ferguson, A; Lee, M; Tzou, S; ... Lee, M; + view all (2013) Design, synthesis, and DNA binding characteristics of a group of orthogonally positioned diamino, N-formamido, pyrrole- and imidazole-containing polyamides. BIOORGANIC & MEDICINAL CHEMISTRY , 21 (13) pp. 3907-3918. 10.1016/j.bmc.2013.04.001.

Childs, A; O'Beirne, J; Meyer, T; (2013) Status of hepatocellular cancer in Europe. Chin Clin Oncol , 2 (4) 44-. 10.3978/j.issn.2304-3865.2013.09.04.

Cho, E-A; Moloney, FJ; Cai, H; Au-Yeung, A; China, C; Scolyer, RA; Yosufi, B; ... Khachigian, LM; + view all (2013) Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a phase 1 first-in-human trial (DISCOVER). LANCET , 381 (9880) pp. 1835-1843. 10.1016/S0140-6736(12)62166-7.

Cho, E-A; Moloney, FJ; Cai, H; Au-Yeung, A; China, C; Scolyer, RA; Yosufi, B; ... Khachigian, LM; + view all (2013) Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a phase 1 first-in-human trial (DISCOVER). Lancet , 381 (9880) pp. 1835-1843. 10.1016/S0140-6736(12)62166-7.

Collins, M; Wilhelm, M; Conyers, R; Herschtal, A; Whelan, J; Bielack, S; Kager, L; ... Thomas, DM; + view all (2013) Benefits and Adverse Events in Younger Versus Older Patients Receiving Neoadjuvant Chemotherapy for Osteosarcoma: Findings From a Meta-Analysis. JOURNAL OF CLINICAL ONCOLOGY , 31 (18) pp. 2303-2312. 10.1200/JCO.2012.43.8598.

Cresti, N; Jodrell, D; Arkenau, T; Forster, M; Donaldson, K; Posner, J; Kawabata, I; ... Spicer, J; + view all (2013) A phase 1 study of S-222611, an oral reversible dual tyrosine kinase inhibitor of EGFR and HER2, in patients with solid tumours. In: (Proceedings) European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO. (pp. S160-S161). ELSEVIER SCI LTD

Creutzberg, CL; Kitchener, HC; Birrer, MJ; Landoni, F; Lu, KH; Powell, M; Aghajanian, C; ... Thomas, G; + view all (2013) Gynecologic Cancer InterGroup (GCIG) Endometrial Cancer Clinical Trials Planning Meeting Taking Endometrial Cancer Trials Into the Translational Era. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , 23 (8) pp. 1528-1534. 10.1097/IGC.0b013e3182a26edb.

Crook, J; Taylor, RM; (2013) The agreement of fingertip and sternum capillary refill time in children. Arch Dis Child , 98 (4) pp. 265-268. 10.1136/archdischild-2012-303046.

Crosby, T; Hurt, CN; Falk, S; Gollins, S; Mukherjee, S; Staffurth, J; Ray, R; ... Griffiths, G; + view all (2013) Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial. LANCET ONCOLOGY , 14 (7) pp. 627-637. 10.1016/S1470-2045(13)70136-0.

D

Datta, RS; Gutteridge, A; Swanton, C; Maley, CC; Graham, TA; (2013) Modelling the evolution of genetic instability during tumour progression. EVOLUTIONARY APPLICATIONS , 6 (1) pp. 20-33. 10.1111/eva.12024.

Davidson, SM; Selvaraj, P; He, D; Boi-Doku, C; Yellon, RL; Vicencio, JM; Yellon, DM; (2013) Remote ischaemic preconditioning involves signalling through the SDF-1 alpha/CXCR4 signalling axis. BASIC RESEARCH IN CARDIOLOGY , 108 (5) 10.1007/s00395-013-0377-6.

Devauges, V; Ortiz-Zapater, E; Efthymiou, C; Keppler, M; Barbeau, J; Matthews, DR; James, MOP; ... Ameer-Beg, SM; + view all (2013) Single Molecule FRET using the FRET pair DRONPA/PhotoActivable mCherry. In: Enderlein, J and Gregor, I and Gryczynski, ZK and Erdmann, R and Koberling, F, (eds.) UNSPECIFIED SPIE-INT SOC OPTICAL ENGINEERING

Dikaios, N; Punwani, S; Hamy, V; Purpura, P; Rice, S; Forster, M; Mendes, R; ... Atkinson, D; + view all (2013) Noise Estimation from Averaged Diffusion Weighted Images: Can Unbiased Quantitative Decay Parameters Assist Cancer Evaluation? Magnetic Resonance in Medicine , 71 (6) pp. 2105-2117. 10.1002/mrm.24877. Green open access
file

Dunn, J; Marshall, A; Campbell, A; Stallard, N; Hulme, C; Hall, P; Higgins, H; ... Stein, R; + view all (2013) Using adaptive designs for decision making within the optima trial: optimal personalized treatment of early breast cancer using multi-parameter tests. In: (pp. O12-O12).

de Bruin, EC; Taylor, TB; Swanton, C; (2013) Intra-tumor heterogeneity: lessons from microbial evolution and clinical implications. GENOME MEDICINE , 5 (ARTN 101) 10.1186/gm505.

E

Eccles, SA; Aboagye, EO; Ali, S; Anderson, AS; Armes, J; Berditchevski, F; Blaydes, JP; ... Thompson, AM; + view all (2013) Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast Cancer Research , 15 (5) , Article R92. 10.1186/bcr3493. Green open access
file

F

Faelber, K; Gao, S; Held, M; Posor, Y; Haucke, V; Noe, F; Daumke, O; (2013) Oligomerization of Dynamin Superfamily Proteins in Health and Disease. OLIGOMERIZATION IN HEALTH AND DISEASE , 117 pp. 411-443. 10.1016/B978-0-12-386931-9.00015-5.

Fern, L; Whelan, J; (2013) National Cancer Research Institute Teenage and Young Adult Clinical Studies Group: The United Kingdom Approach to Research. International Perspectives on AYAO, Part 4. J Adolesc Young Adult Oncol , 2 (4) pp. 161-166. 10.1089/jayao.2012.0030.

Fern, LA; Birch, R; Whelan, J; Cooke, M; Sutton, S; Neal, RD; Gerrand, C; ... Gibson, F; + view all (2013) Why can't we improve the timeliness of cancer diagnosis in children, teenagers, and young adults? BMJ , 347 f6493-. 10.1136/bmj.f6493.

Fern, LA; Taylor, RM; Whelan, J; Pearce, S; Grew, T; Brooman, K; Starkey, C; ... Gibson, F; + view all (2013) The art of age-appropriate care: reflecting on a conceptual model of the cancer experience for teenagers and young adults. Cancer Nurs , 36 (5) E27-E38. 10.1097/NCC.0b013e318288d3ce.

Fisher, R; Pusztai, L; Swanton, C; (2013) Cancer heterogeneity: implications for targeted therapeutics. BRITISH JOURNAL OF CANCER , 108 (3) pp. 479-485. 10.1038/bjc.2012.581.

Flynn, M; Shapiro, G; LoRusso, P; Kristeleit, R; Patel, M; Infante, J; Giordano, H; ... Burris, H; + view all (2013) A Phase I Dose-escalation and PK Study of continuous oral Rucaparib in Patients with advanced solid Tumors. European journal of cancer , 49 (Suppl 2) 10.1016/S0959-8049(13)70061-3.

Forshew, T; Lewis, P; Waldman, A; Peterson, D; Glaser, M; Brock, C; Sheer, D; (2013) Three different brain tumours evolving from a common origin. ONCOGENESIS , 2 (UNSP e41) 10.1038/oncsis.2013.1.

Foukas, LC; Bilanges, B; Bettedi, L; Pearce, W; Ali, K; Sancho, S; Withers, DJ; (2013) Long-term p110 PI3K inactivation exerts a beneficial effect on metabolism. EMBO MOLECULAR MEDICINE , 5 (4) pp. 563-571. 10.1002/emmm.201201953. Gold open access

Francis, JM; Kiezun, A; Ramos, AH; Serra, S; Pedamallu, CS; Qian, ZR; Banck, MS; ... Meyerson, M; + view all (2013) Somatic mutation of CDKN1B in small intestine neuroendocrine tumors. NATURE GENETICS , 45 (12) 1483-U110. 10.1038/ng.2821.

Francis, JM; Kiezun, A; Ramos, AH; Serra, S; Pedamallu, CS; Qian, ZR; Banck, MS; ... Meyerson, M; + view all (2013) Somatic mutation of CDKN1B in small intestine neuroendocrine tumors. Nature Genetics , 45 (12) pp. 1483-1486. 10.1038/ng.2821.

G

Ganguli, S; Benafif, S; Kirkwood, A; Flynn, M; Forster, M; Kristeleit, RS; Meyer, T; (2013) Clinical outcomes of patients treated within early phase cancer trials: An audit of the NIHR/Wellcome UCLH clinical research facility. In: (pp. S182-S182). Elsevier

Gerlinger, M; Norton, L; Swanton, C; (2013) Acquired Resistance to Crizotinib from a Mutation in CD74-ROS1. NEW ENGLAND JOURNAL OF MEDICINE , 369 (12) pp. 1172-1173. 10.1056/NEJMc1309091.

Gerlinger, M; Quezada, SA; Peggs, KS; Furness, AJS; Fisher, R; Marafioti, T; Shende, VH; ... Swanton, C; + view all (2013) Ultra-deep T cell receptor sequencing reveals the complexity and intratumour heterogeneity of T cell clones in renal cell carcinomas. JOURNAL OF PATHOLOGY , 231 (4) pp. 424-432. 10.1002/path.4284.

Gibson, F; Pearce, S; Eden, T; Glaser, A; Hooker, L; Whelan, J; Kelly, D; (2013) Young people describe their prediagnosis cancer experience. Psychooncology , 22 (11) pp. 2585-2592. 10.1002/pon.3325.

Gibson, F; Shipway, L; Aldiss, S; Hawkins, J; King, W; Parr, M; Ridout, D; ... Taylor, RM; + view all (2013) Exploring the work of nurses who administer chemotherapy to children and young people. EUROPEAN JOURNAL OF ONCOLOGY NURSING , 17 (1) pp. 59-69. 10.1016/j.ejon.2012.01.006.

Goldstein, R; Sosabowski, J; Vigor, K; Chester, K; Meyer, T; (2013) Developments in single photon emission computed tomography and PET-based HER2 molecular imaging for breast cancer. EXPERT REVIEW OF ANTICANCER THERAPY , 13 (3) pp. 359-373. 10.1586/ERA.13.11.

Goy, A; Ribrag, V; Varga, A; Witzig, TE; Ocio, EM; Paz-Ares, LG; Mita, MM; ... Hege, K; + view all (2013) Phase I expansion trial of an oral TORC1/TORC2 inhibitor (CC-223) in diffuse large B-cell lymphoma (DLBCL) and multiple myeloma (MM). In: (Proceedings) 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO). AMER SOC CLINICAL ONCOLOGY

H

Hall, P; McCabe, C; Hulme, C; Edlin, R; Dunn, J; Cameron, D; Stein, R; (2013) Efficient design of a phase III trial of competing tests for personalised cancer treatment in the absence of gold standard outcome data: challenges and potential solutions. In: (pp. O5-O5).

Hartley, JA; Masterson, L; Gregson, S; Cailleau, T; Ezeadi, E; Levy, J-N; Kemp, G; ... Howard, PW; + view all (2013) Pyrrolobenzodiazepine (PBD) dimers - potent next generation warheads in antibody drug conjugates (ADCs) targeted at both solid and haematological tumors. In:

Hemmerle, T; Probst, P; Giovannoni, L; Green, AJ; Meyer, T; Neri, D; (2013) The antibody-based targeted delivery of TNF in combination with doxorubicin eradicates sarcomas in mice and confers protective immunity. BRITISH JOURNAL OF CANCER , 109 (5) pp. 1206-1213. 10.1038/bjc.2013.421.

Hochhauser, D; Glynne-Jones, R; Potter, V; Gravalos, C; Doyle, TJ; Pathiraja, K; Zhang, Q; ... Sausville, EA; + view all (2013) A Phase II Study of Temozolomide in Patients with Advanced Aerodigestive Tract and Colorectal Cancers and Methylation of the O-6-Methylguanine-DNA Methyltransferase Promoter. MOLECULAR CANCER THERAPEUTICS , 12 (5) pp. 809-818. 10.1158/1535-7163.MCT-12-0710.

Horswell, S; Matthews, N; Swanton, C; (2013) Cancer heterogeneity and "The Struggle for Existence": Diagnostic and analytical challenges. CANCER LETTERS , 340 (2) pp. 220-226. 10.1016/j.canlet.2012.10.031.

Hudis, C; Swanton, C; Janjigian, YY; Lee, R; Sutherland, S; Lehman, R; Chandarlapaty, S; ... Han, HS; + view all (2013) A phase 1 study evaluating the combination of an allosteric AKT inhibitor (MK-2206) and trastuzumab in patients with HER2-positive solid tumors. BREAST CANCER RESEARCH , 15 (6) 10.1186/bcr3577.

Hynds, RE; Giangreco, A; (2013) Concise review: the relevance of human stem cell-derived organoid models for epithelial translational medicine. Stem Cells , 31 (3) 417 - 422. 10.1002/stem.1290. Green open access
file

I

Ibarra, C; Vicencio, JM; Estrada, M; Lin, Y; Rocco, P; Rebellato, P; Munoz, JP; ... Lavandero, S; + view all (2013) Local Control of Nuclear Calcium Signaling in Cardiac Myocytes by Perinuclear Microdomains of Sarcolemmal Insulin-Like Growth Factor 1 Receptors. CIRCULATION RESEARCH , 112 (2) 236-+. 10.1161/CIRCRESAHA.112.273839.

Infante, JR; Arkenau, H-T; Bendell, JC; Rubin, MS; Waterhouse, D; Jones, GT; Spigel, DR; ... Burris, HA; + view all (2013) Lenalidomide in combination with gemcitabine as first-line treatment for patients with metastatic carcinoma of the pancreas A Sarah Cannon Research Institute phase II trial. CANCER BIOLOGY & THERAPY , 14 (4) pp. 340-346. 10.4161/cbt.23625.

J

Jamal-Hanjani, M; Karpathakis, A; Kwan, A; Mazhar, D; Ansell, W; Shamash, J; Harper, P; ... Chowdhury, S; + view all (2013) Bone metastases in germ cell tumours: lessons learnt from a large retrospective study. BJU INTERNATIONAL , 112 (2) pp. 176-181. 10.1111/bju.12218.

Jamal-Hanjani, M; Thanopoulou, E; Peggs, KS; Quezada, SA; Swanton, C; (2013) Tumour heterogeneity and immune-modulation. Curr Opin Pharmacol , 13 (4) 497 - 503. 10.1016/j.coph.2013.04.006. Green open access
file

Jeynes, JCG; Merchant, MJ; Barazzuol, L; Barry, M; Guest, D; Palitsin, VV; Grime, GW; ... Kirkby, KJ; + view all (2013) "Broadbeam" irradiation of mammalian cells using a vertical microbeam facility. Radiat Environ Biophys , 52 (4) pp. 513-521. 10.1007/s00411-013-0487-4.

K

Kadalayil, L; Benini, R; Pallan, L; O'Beirne, J; Marelli, L; Yu, D; Hackshaw, A; ... Meyer, T; + view all (2013) A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer. Ann Oncol , 24 (10) pp. 2565-2570. 10.1093/annonc/mdt247. Green open access
file

Karpathakis, A; Dibra, H; Thirlwell, C; (2013) Neuroendocrine tumours: cracking the epigenetic code. ENDOCRINE-RELATED CANCER , 20 (3) R65-R82. 10.1530/ERC-12-0338.

Karpathakis, A; Pericleous, M; Luong, TV; Khoo, B; Thirlwell, C; Toumpanakis, C; Caplin, ME; (2013) Pancreatic adenocarcinoma in a patient with multiple endocrine neoplasia 1 syndrome. Pancreas , 42 (4) 725 - 726. 10.1097/MPA.0b013e31827591e9. Green open access
file

Khan, MS; (2013) Circulating Tumour Cells and Biomarkers in Neuroendocrine Tumours. Doctoral thesis , UCL (University College London). Green open access
file

Khan, MS; Kirkwood, A; Tsigani, T; Garcia-Hernandez, J; Hartley, JA; Caplin, ME; Meyer, T; (2013) Circulating Tumor Cells As Prognostic Markers in Neuroendocrine Tumors. In: (pp. pp. 365-372). AMER SOC CLINICAL ONCOLOGY

Khan, MS; Luong, TV; Watkins, J; Toumpanakis, C; Caplin, ME; Meyer, T; (2013) A comparison of Ki-67 and mitotic count as prognostic markers for metastatic pancreatic and midgut neuroendocrine neoplasms. BRITISH JOURNAL OF CANCER , 108 (9) pp. 1838-1845. 10.1038/bjc.2013.156.

Khattak, MA; Bakr, F; Krzystanek, M; Szallasi, Z; Gerlinger, M; Santos, C; Swanton, C; ... Larkin, JMG; + view all (2013) Prognostic and Predictive Markers in Metastatic Renal Cell Carcinoma. JOURNAL OF CLINICAL ONCOLOGY , 31 (7) pp. 971-972. 10.1200/JCO.2012.46.9353.

Khoja, L; Meyer, T; Waters, J; Wadesley, J; Ma, Y; Eatock, M; Williams, H; ... Valle, JW; + view all (2013) Sunitinib (S) and everolimus (E) in pancreatic neuroendocrine tumours (pNETs): A retrospective UKINETS study. In: (Proceedings) European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO. (pp. S626-S627). ELSEVIER SCI LTD

King, J; Johnson, P; Palmer, D; Ross, P; Hubner, R; Graham, J; Darby, S; ... Meyer, T; + view all (2013) UK audit of sorafenib for advanced hepatocellular cancer. In: (Proceedings) European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO. (pp. S622-S622). ELSEVIER SCI LTD

Kogelberg, H; Miranda, E; Burnet, J; Ellison, D; Tolner, B; Foster, J; Picón, C; ... Chester, K; + view all (2013) Generation and Characterization of a Diabody Targeting the αvβ6 Integrin. PLoS One , 8 (9) , Article e73260. 10.1371/journal.pone.0073260. Green open access
file

Kristeleit, RS; Shapiro, G; LoRusso, P; Infante, JR; Flynn, M; Patel, MR; Tolaney, SM; ... Burris, HA; + view all (2013) A phase I dose-escalation and PK study of continuous oral rucaparib in patients with advanced solid tumors. Journal of Clinical Oncology , 31 (Suppl 1)

Kristeleit, RS; Shapiro, G; LoRusso, P; Infante, JR; Flynn, M; Patel, MR; Tolaney, SM; ... Burris, HA; + view all (2013) A phase I dose-escalation and PK study of continuous oral rucaparib in patients with advanced solid tumors. In: (Proceedings) 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO). AMER SOC CLINICAL ONCOLOGY

Kularatne, B; Capitanio, A; Arora, R; Jones, P; Lopes, A; Paterson, J; Kristeleit, R; (2013) PTEN and p53 expression in endometrial cancer correlated with clinicopathological phenotype. MOLECULAR CANCER THERAPEUTICS , 12 (11) 10.1158/1535-7163.TARG-13-C32.

L

Lassen, U; Miller, W; Hotte, S; Evans, J; Kollmansberger, C; Adamson, D; Nielsen, LD; ... Sawyer, M; + view all (2013) Phase I evaluation of the effects of ketoconazole and rifampicin on cediranib pharmacokinetics in patients with solid tumours. Cancer Chemotherapy and Pharmacology , 71 (2) pp. 543-549. 10.1007/s00280-012-2038-0.

Lechner, M; Fenton, T; West, J; Wilson, G; Feber, A; Henderson, S; Thirlwell, C; ... Beck, S; + view all (2013) Identification and functional validation of HPV-mediated hypermethylation in head and neck squamous cell carcinoma. Genome Medicine , 5 (2) p. 15. 10.1186/gm419. Green open access
file

Lechner, M; Frampton, G; Fenton, T; Feber, A; Palmer, G; Jay, A; Pillay, N; ... Boshoff, C; + view all (2013) Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV+ and HPV- tumors. Genome Medicine , 5 , Article 49. 10.1186/gm453. Green open access
file

Lee, JLC; Hynds, RE; (2013) Divergent cellular pathways of hippocampal memory consolidation and reconsolidation. HIPPOCAMPUS , 23 (3) pp. 233-244. 10.1002/hipo.22083.

Lee, M; Chavda, S; Babu, B; Patil, P; Plaunt, A; Ferguson, A; Lee, M; ... Hartley, JA; + view all (2013) Design, synthesis, and DNA binding characteristics of a group of orthogonally positioned diamino, N-formamido, pyrrole- and imidazole-containing polyamides. Bioorganic and Medicinal Chemistry , 21 (13) pp. 3907-3918. 10.1016/j.bmc.2013.04.001.

Lemech, C; Infante, J; Arkenau, H-T; (2013) Combination Molecularly Targeted Drug Therapy in Metastatic Melanoma: Progress to Date. DRUGS , 73 (8) pp. 767-777. 10.1007/s40265-013-0049-8.

Lemech, CR; Arkenau, H-T; (2013) The future is here: tumour profiling in day-to-day clinical practice. DRUG DISCOVERY TODAY , 18 (15-16) pp. 689-691. 10.1016/j.drudis.2013.06.006.

Lemech, CR; Arkenau, H-T; (2013) The future is here: tumour profiling in day-to-day clinical practice. Drug Discov Today , 18 (15-16) pp. 689-691. 10.1016/j.drudis.2013.06.006.

Lin, S; Kiakos, K; Plaunt, A; Mackay, H; Babu, B; Patil, P; Hochhauser, D; ... Lee, M; + view all (2013) Control of the human DBf4 gene by a small pyrrole and imidazole-containing polyamide (f-IPI) andnot its H-pin analog (f-IPI2). In: (Proceedings) 245th National Spring Meeting of the American-Chemical-Society (ACS). AMER CHEMICAL SOC

Lu, L; Teixeira, VH; Yuan, Z; Graham, TA; Endesfelder, D; Kolluri, K; Al-Juffali, N; ... Janes, SM; + view all (2013) LRIG1 regulates cadherin-dependent contact inhibition directing epithelial homeostasis and pre-invasive squamous cell carcinoma development. J Pathol , 229 (4) 608 - 620. 10.1002/path.4148. Green open access
file

Lu, M; Breyssens, H; Salter, V; Zhong, S; Hu, Y; Baer, C; Ratnayaka, I; ... Lu, X; + view all (2013) Restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1/CDK1-phosphorylated nuclear iASPP. Cancer Cell , 23 (5) pp. 618-633. 10.1016/j.ccr.2013.03.013.

M

Martinez, P; Birkbak, NJ; Gerlinger, M; McGranahan, N; Burrell, RA; Rowan, AJ; Joshi, T; ... Swanton, C; + view all (2013) Parallel evolution of tumour subclones mimics diversity between tumours. JOURNAL OF PATHOLOGY , 230 (4) pp. 356-364. 10.1002/path.4214.

Martinez, P; McGranahan, N; Birkbak, NJ; Gerlinger, M; Swanton, C; (2013) Computational optimisation of targeted DNA sequencing for cancer detection. SCIENTIFIC REPORTS , 3 (ARTN 330) 10.1038/srep03309.

Martínez-Cadenas, C; López, S; Ribas, G; Flores, C; García, O; Sevilla, A; Smith-Zubiaga, I; ... Alonso, S; + view all (2013) Simultaneous Purifying Selection on the Ancestral MC1R Allele and Positive Selection on the Melanoma-Risk Allele V60L in South Europeans. Molecular Biology and Evolution , 30 (12) pp. 2654-2665. 10.1093/molbev/mst158.

Massard, C; Margetts, J; Amellal, N; Drew, Y; Bahleda, R; Stephens, P; Armand, JP; ... Plummer, R; + view all (2013) Phase I study of PM00104 (Zalypsis (R)) administered as a 1-hour weekly infusion resting every fourth week in patients with advanced solid tumors (vol 31, pg 623, 2013). INVESTIGATIONAL NEW DRUGS , 31 (3) p. 799. 10.1007/s10637-013-9954-7.

Massard, C; Margetts, J; Amellal, N; Drew, Y; Bahleda, R; Stevens, P; Armand, JP; ... Plummer, R; + view all (2013) Phase I study of PM00104 (Zalypsis (R)) administered as a 1-hour weekly infusion resting every fourth week in patients with advanced solid tumors. INVESTIGATIONAL NEW DRUGS , 31 (3) pp. 623-630. 10.1007/s10637-012-9843-5.

McNeish, IA; Ledermann, JA; Webber, LC; James, LE; Kaye, SB; Rustin, GJS; Hall, G; ... Khan, I; + view all (2013) A randomized placebo-controlled trial of saracatinib (AZD0530) plus weekly paclitaxel in platinum-resistant ovarian, fallopian-tube, or primary peritoneal cancer (SaPPrOC). In: (Proceedings) 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO). AMER SOC CLINICAL ONCOLOGY

Mendoza-Naranjo, A; El-Naggar, A; Wai, DH; Mistry, P; Lazic, N; Ayala, FR; da Cunha, IW; ... Sorensen, PH; + view all (2013) ERBB4 confers metastatic capacity in Ewing sarcoma. EMBO Mol Med , 5 (7) 1019 - 1034. 10.1002/emmm.201202343. Green open access
file

Meyer, T; (2013) Primary liver cancer. Br J Cancer , 108 (4) pp. 995-996. 10.1038/bjc.2013.52.

Meyer, T; Khan, MS; (2013) Are Circulating Tumor Cells a New, Valid Prognostic Marker in Neuroendocrine Tumors? Reply. JOURNAL OF CLINICAL ONCOLOGY , 31 (19) p. 2519. 10.1200/JCO.2013.49.9053.

Meyer, T; Kirkwood, A; Roughton, M; Beare, S; Tsochatzis, E; Yu, D; Davies, N; ... Burroughs, AK; + view all (2013) A randomised phase II/III trial of 3-weekly cisplatin-based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinoma. BRITISH JOURNAL OF CANCER , 108 (6) pp. 1252-1259. 10.1038/bjc.2013.85.

Middleton, G; Brown, S; Lowe, C; Maughan, T; Gwyther, S; Oliver, A; Richman, S; ... Seymour, M; + view all (2013) A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: Results of the Panitumumab, Irinotecan & Ciclosporin in COLOrectal cancer therapy trial (PICCOLO). EUROPEAN JOURNAL OF CANCER , 49 (16) pp. 3507-3516. 10.1016/j.ejca.2013.06.017.

Mita, MM; Wolin, EM; Meyer, T; Nemunaitis, JJ; Bergsland, EK; Mahipal, A; Wong, L; ... Bendell, JC; + view all (2013) Phase I expansion trial of an oral TORC1/TORC2 inhibitor (CC-223) in nonpancreatic neuroendocrine tumors (NET). In: (Proceedings) 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO). AMER SOC CLINICAL ONCOLOGY

Moniz, LS; Vanhaesebroeck, B; (2013) AKT-ing out: SGK kinases come to the fore. Biochem J , 452 (3) e11-e13. 10.1042/BJ20130617.

Moorcraft, SY; Chau, I; Peckitt, C; Cunningham, D; Rao, S; Yim, KL; Walther, A; ... Swanton, C; + view all (2013) Patupilone in patients with pretreated metastatic/locally recurrent colorectal cancer: results of the Phase II CINATRA trial. INVESTIGATIONAL NEW DRUGS , 31 (5) pp. 1339-1344. 10.1007/s10637-013-9990-3.

Mukherjee, S; Hurt, CN; Bridgewater, J; Falk, S; Cummins, S; Wasan, H; Crosby, T; ... Maughan, T; + view all (2013) Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial. LANCET ONCOLOGY , 14 (4) pp. 317-326. 10.1016/S1470-2045(13)70021-4.

Munoz, J; Swanton, C; Kurzrock, R; (2013) Molecular profiling and the reclassification of cancer: divide and conquer. Am Soc Clin Oncol Educ Book pp. 127-134. 10.1200/EdBook_AM.2013.33.127.

Murugaesu, N; Chew, SK; Swanton, C; (2013) Adapting Clinical Paradigms to the Challenges of Cancer Clonal Evolution. AMERICAN JOURNAL OF PATHOLOGY , 182 (6) pp. 1962-1971. 10.1016/j.ajpath.2013.02.026.

N

Nathanson, KL; Martin, A-M; Wubbenhorst, B; Greshock, J; Letrero, R; D'Andrea, K; O'Day, S; ... Long, GV; + view all (2013) Tumor Genetic Analyses of Patients with Metastatic Melanoma Treated with the BRAF Inhibitor Dabrafenib (GSK2118436). CLINICAL CANCER RESEARCH , 19 (17) pp. 4868-4878. 10.1158/1078-0432.CCR-13-0827.

Ng, T; Irshad, S; Stebbing, J; (2013) BRCA1 mutations and luminal-basal transformation. ONCOGENE , 32 (22) pp. 2712-2714. 10.1038/onc.2012.379.

O

Omlin, A; Pezaro, C; Mukherji, D; Cassidy, AM; Sandhu, S; Bianchini, D; Olmos, D; ... de Bono, J; + view all (2013) Improved Survival in a Cohort of Trial Participants with Metastatic Castration-resistant Prostate Cancer Demonstrates the Need for Updated Prognostic Nomograms. EUROPEAN UROLOGY , 64 (2) pp. 300-306. 10.1016/j.eururo.2012.12.029.

Oxenham, T; Southern, P; Briesemeister, D; Freeman, A; Peggs, K; Pankhurst, Q; Quezada, S; (2013) Development of Hyperthermia Treatments for Malignant Melanoma using Superparamagnetic Iron Oxide Nanoparticles in a Novel Transgenic In Vivo Model. In: (pp. p. 58). WILEY-BLACKWELL

P

Paz-Ares, L; Calvo, E; Forster, M; Boni, V; Lopez Calderero, I; Benafif, S; Kahatt, C; ... Szyldergemajn, S; + view all (2013) CLINICAL ACTIVITY OF LURBINECTEDIN (PM01183) IN COMBINATION WITH GEMCITABINE (GEM) IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS (PTS): PRELIMINARY SUBGROUP ANALYSIS OF A PHASE IB STUDY. In: (pp. S569-S569). LIPPINCOTT WILLIAMS & WILKINS

Pearce, S; Lavender, V; Brownsdon, A; Gibson, F; Fern, L; Whelan, J; (2013) Perceptions of participants and professionals in bone sarcoma clinical trials: Implications for study design and conduct. In: (Proceedings) European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO. (pp. S882-S882). ELSEVIER SCI LTD

Pezaro, C; Mukherji, D; Tunariu, N; Cassidy, AM; Omlin, A; Bianchini, D; Seed, G; ... Attard, G; + view all (2013) Sarcopenia and change in body composition following maximal androgen suppression with abiraterone in men with castration-resistant prostate cancer. BRITISH JOURNAL OF CANCER , 109 (2) pp. 325-331. 10.1038/bjc.2013.340.

Plummer, R; Lorigan, P; Brown, E; Zaucha, R; Moiseyenko, V; Demidov, L; Soriano, V; ... Calvert, H; + view all (2013) Phase I-II study of plitidepsin and dacarbazine as first-line therapy for advanced melanoma. BRITISH JOURNAL OF CANCER , 109 (6) pp. 1451-1459. 10.1038/bjc.2013.477.

Plummer, R; Lorigan, P; Steven, N; Scott, L; Middleton, MR; Wilson, RH; Mulligan, E; ... Calvert, H; + view all (2013) A phase II study of the potent PARP inhibitor, Rucaparib (PF-01367338, AG014699), with temozolomide in patients with metastatic melanoma demonstrating evidence of chemopotentiation. CANCER CHEMOTHERAPY AND PHARMACOLOGY , 71 (5) pp. 1191-1199. 10.1007/s00280-013-2113-1.

Popat, R; Maharaj, L; Oakervee, H; Cavenagh, J; Joel, S; (2013) Schedule dependent cytotoxicity of bortezomib and melphalan in multiple myeloma. BRITISH JOURNAL OF HAEMATOLOGY , 160 (1) pp. 111-114. 10.1111/bjh.12089.

Posor, Y; Eichhorn-Gruenig, M; Puchkov, D; Schoeneberg, J; Ullrich, A; Lampe, A; Mueller, R; ... Haucke, V; + view all (2013) Spatiotemporal control of endocytosis by phosphatidylinositol-3,4-bisphosphate. NATURE , 499 (7457) 233-+. 10.1038/nature12360.

Q

Quiroga, C; Gatica, D; Paredes, F; Bravo, R; Troncoso, R; Pedrozo, Z; Rodriguez, AE; ... Lavandero, S; + view all (2013) Herp depletion protects from protein aggregation by up-regulating autophagy. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH , 1833 (12) pp. 3295-3305. 10.1016/j.bbamcr.2013.09.006.

R

Rahman, KM; Jackson, PJM; James, CH; Basu, BP; Hartley, JA; de la Fuente, M; Schatzlein, A; ... Thurston, DE; + view all (2013) GC-t8-linked pyrrolobenzodiazepine (PBD)-biaryl conjugates with femptomolar in vitro cytotoxicity and in vivo antitumour activity in mouse models of pancreatic and breast cancer. In:

Rahman, KM; Jackson, PJM; James, CH; Basu, BP; Hartley, JA; de la Fuente, M; Schatzlein, A; ... Thurston, DE; + view all (2013) GC-Targeted C8-Linked Pyrrolobenzodiazepine-Biaryl Conjugates with Femtomolar in Vitro Cytotoxicity and in Vivo Antitumor Activity in Mouse Models. JOURNAL OF MEDICINAL CHEMISTRY , 56 (7) pp. 2911-2935. 10.1021/jm301882a.

Rajasekaran, K; Kumar, P; Schuldt, KM; Peterson, EJ; Vanhaesebroeck, B; Dixit, V; Thakar, MS; (2013) Signaling by Fyn-ADAP via the Carma1-Bcl-10-MAP3K7 signalosome exclusively regulates inflammatory cytokine production in NK cells. NATURE IMMUNOLOGY , 14 (11) 1127-U122. 10.1038/ni.2708.

Rajasekaran, K; Kumar, P; Schuldt, KM; Peterson, EJ; Vanhaesebroeck, B; Dixit, V; Thakar, MS; (2013) Signaling by Fyn-ADAP via the Carma1-Bcl-10-MAP3K7 signalosome exclusively regulates inflammatory cytokine production in NK cells. Nature Immunology , 14 (11) pp. 1127-1136. 10.1038/ni.2708.

Rajeeve, V; Pearce, W; Cascante, M; Vanhaesebroeck, B; Cutillas, PR; (2013) Polyamine production is downstream and upstream of oncogenic PI3K signalling and contributes to tumour cell growth. BIOCHEMICAL JOURNAL , 450 pp. 619-628. 10.1042/BJ20121525.

Ramos, JP; Babu, B; Chavda, S; Liu, Y; Plaunt, A; Ferguson, A; Savagian, M; ... Wilson, WD; + view all (2013) Affinity and kinetic modulation of polyamideDNA interactions by N-modification of the heterocycles. BIOPOLYMERS , 99 (8) pp. 497-507. 10.1002/bip.22205.

Rashid, M; Teixeira, AS; Qureshi, U; Pereira, SP; Novelli, MR; Swallow, DM; (2013) Apical MUC1 expression revealed on the foveolar epithelium in H. pylori gastritis. BRITISH JOURNAL OF CANCER , 108 (5) pp. 1113-1118. 10.1038/bjc.2013.54.

Rashid, M; Teixeira, AS; Qureshi, U; Pereira, SP; Novelli, MR; Swallow, DM; (2013) Apical MUC1 expression revealed on the foveolar epithelium in H. pylori gastritis. British Journal of Cancer , 108 (5) pp. 1113-1118. 10.1038/bjc.2013.54.

Read, RD; Fenton, TR; Gomez, GG; Wykosky, J; Vandenberg, SR; Babic, I; Yang, H; ... Thomas, JB; + view all (2013) A Kinome-Wide RNAi Screen in Drosophila Glia Reveals That the RIO Kinases Mediate Cell Proliferation and Survival through TORC2-Akt Signaling in Glioblastoma. PLoS Genetics , 9 (2) , Article e1003253. 10.1371/journal.pgen.1003253. Green open access
file

Richardson, SE; (2013) Modelling how initiating and transforming oncogenes cooperate to produce a leukaemic cell state. DISEASE MODELS & MECHANISMS , 6 (1) pp. 3-5. 10.1242/dmm.011288. Gold open access

Richardson, SE; Khan, I; Rawstron, A; Sudak, J; Edwards, N; Verfuerth, S; Fielding, AK; ... Chakraverty, R; + view all (2013) Risk-stratified adoptive cellular therapy following allogeneic hematopoietic stem cell transplantation for advanced chronic lymphocytic leukaemia. British Journal of Haematology , 160 (5) pp. 640-648. 10.1111/bjh.12197.

Rodriguez-Galan, O; Jose Garcia-Gomez, J; de la Cruz, J; (2013) Yeast and human RNA helicases involved in ribosome biogenesis: Current status and perspectives. BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS , 1829 (8) pp. 775-790. 10.1016/j.bbagrm.2013.01.007.

Rodriguez-Peralvarez, M; Tu, VL; Andreana, L; Meyer, T; Dhillon, AP; Burroughs, AK; (2013) A Systematic Review of Microvascular Invasion in Hepatocellular Carcinoma: Diagnostic and Prognostic Variability. ANNALS OF SURGICAL ONCOLOGY , 20 (1) pp. 325-339. 10.1245/s10434-012-2513-1.

S

Saggese, M; Dua, D; Simmons, E; Lemech, C; Arkenau, HT; (2013) Research biopsies in the context of early phase oncology studies: Clinical and ethical considerations. Oncology Reviews , 7 (1) pp. 34-37. 10.4081/oncol.2013.e5.

Sandhu, SK; Schelman, WR; Wilding, G; Moreno, V; Baird, RD; Miranda, S; Hylands, L; ... Wenham, RM; + view all (2013) The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial. LANCET ONCOLOGY , 14 (9) pp. 882-892. 10.1016/S1470-2045(13)70240-7.

Santoro, V; Hartley, JA; Hochhauser, D; (2013) Interaction between cetuximab and chemotherapy in colon cancer. In: (Proceedings) 104th Annual Meeting of the American-Association-for-Cancer-Research (AACR). AMER ASSOC CANCER RESEARCH

Satam, V; Patil, P; Babu, B; Gregory, M; Bowerman, M; Savagian, M; Lee, M; ... Lee, M; + view all (2013) Hx-amides: DNA sequence recognition by the fluorescent Hx (p-anisylbenzimidazole)circle pyrrole and Hx center dot imidazole pairings. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS , 23 (6) pp. 1699-1702. 10.1016/j.bmcl.2013.01.075.

Satam, V; Patil, P; Babu, B; Gregory, M; Bowerman, M; Savagian, M; Lee, M; ... Lee, M; + view all (2013) Hx-amides: DNA sequence recognition by the fluorescent Hx (p-anisylbenzimidazole)•pyrrole and Hx•imidazole pairings. Bioorganic and Medicinal Chemistry Letters , 23 (6) pp. 1699-1702. 10.1016/j.bmcl.2013.01.075.

Schumacher, FF; Sanchania, VA; Tolner, B; Wright, ZV; Ryan, CP; Smith, ME; Ward, JM; ... Baker, JR; + view all (2013) Homogeneous antibody fragment conjugation by disulfide bridging introduces 'spinostics'. [Magazine_article]. Scientific Reports , 3 , Article 1525. 10.1038/srep01525. Green open access
filefile

Seymour, LK; Calvert, AH; Lobbezoo, MW; Eisenhauer, EA; Giaccone, G; (2013) Design and conduct of early clinical studies of two or more targeted anticancer therapies: Recommendations from the task force on Methodology for the Development of Innovative Cancer Therapies. EUROPEAN JOURNAL OF CANCER , 49 (8) pp. 1808-1814. 10.1016/j.ejca.2013.01.014.

Shapiro, G; Kristeleit, R; Middleton, M; Burris, H; Molife, LR; Evans, J; Wilson, R; ... Plummer, R; + view all (2013) Abstract A218: Pharmacokinetics of orally administered rucaparib in patients with advanced solid tumors. Molecular Cancer Therapeutics , 12 (11_Suppl) A218-A218. 10.1158/1535-7163.TARG-13-A218.

Shiu, K-K; Maughan, T; Wilson, RH; Adams, RA; Pugh, C; Brown, L; Fisher, D; ... Kaplan, RS; + view all (2013) FOCUS4: A prospective molecularly stratified, adaptive multicenter program of randomized controlled trials for patients with colorectal cancer (CRC). In: (Proceedings) 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO). AMER SOC CLINICAL ONCOLOGY

Soler, A; Serra, H; Pearce, W; Angulo, A; Guillermet-Guibert, J; Friedman, LS; Vinals, F; ... Vanhaesebroeck, B; + view all (2013) Inhibition of the p110 alpha isoform of PI 3-kinase stimulates nonfunctional tumor angiogenesis. JOURNAL OF EXPERIMENTAL MEDICINE , 210 (10) pp. 1937-1945. 10.1084/jem.20121571.

Swanton, C; (2013) Plasma-Derived Tumor DNA Analysis at Whole-Genome Resolution. CLINICAL CHEMISTRY , 59 (1) pp. 6-8. 10.1373/clinchem.2012.197053.

Szasz, AM; Acs, B; Agoston, E; Sztupinszki, Z; Tokes, A-M; Szittya, L; Szekely, B; ... Kulka, J; + view all (2013) Prediction of the prognosis of breast cancer in routine histologic specimens using a simplified, low-cost gene expression signature. ORVOSI HETILAP , 154 (16) pp. 627-632. 10.1556/OH.2013.29590.

Szasz, AM; Li, Q; Eklund, AC; Sztupinszki, Z; Rowan, A; Tokes, A-M; Szekely, B; ... Kulka, J; + view all (2013) The CIN4 Chromosomal Instability qPCR Classifier Defines Tumor Aneuploidy and Stratifies Outcome in Grade 2 Breast Cancer. PLOS ONE , 8 (2) 10.1371/journal.pone.0056707.

Szekely, B; Iwamoto, T; Szasz, AM; Qi, Y; Matsuoka, J; Symmans, WF; Tokes, A-M; ... Pusztai, L; + view all (2013) A 3-gene proliferation score (TOP-FOX-67) can re-classify histological grade-2, ER-positive breast cancers into low- and high-risk prognostic categories. BREAST CANCER RESEARCH AND TREATMENT , 138 (3) pp. 691-698. 10.1007/s10549-013-2475-4.

T

Taylor, RM; Pearce, S; Gibson, F; Fern, L; Whelan, J; (2013) Developing a conceptual model of teenage and young adult experiences of cancer through meta-synthesis. Int J Nurs Stud , 50 (6) pp. 832-846. 10.1016/j.ijnurstu.2012.09.011.

Teixeira, VH; Nadarajan, P; Graham, TA; Pipinikas, CP; Brown, JM; Falzon, M; Nye, E; ... Janes, SM; + view all (2013) Stochastic homeostasis in human airway epithelium is achieved by neutral competition of basal cell progenitors. ELIFE , 2 (ARTN e00) 10.7554/eLife.00966.

Teschendorff, AE; Marabita, F; Lechner, M; Bartlett, T; Tegner, J; Gomez-Cabrero, D; Beck, S; (2013) A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data. Bioinformatics , 29 (2) 189 - 196. 10.1093/bioinformatics/bts680. Green open access
file

Thrumurthy, SG; Chaudry, MA; Hochhauser, D; Mughal, M; (2013) The diagnosis and management of gastric cancer. BMJ-BRITISH MEDICAL JOURNAL , 347 (ARTN f63) 10.1136/bmj.f6367.

Tookman, L; Rashid, S; Matakidou, A; Phillips, M; Wilson, P; Ansell, W; Jamal-Hanjani, M; ... Shamash, J; + view all (2013) Carboplatin AUC 10 for IGCCCG good prognosis metastatic seminoma. ACTA ONCOLOGICA , 52 (5) pp. 987-993. 10.3109/0284186X.2012.714078.

Tsochatzis, E; Garcovich, M; Marelli, L; Papastergiou, V; Fatourou, E; Rodriguez-Peralvarez, ML; Germani, G; ... Burroughs, AK; + view all (2013) Transarterial embolization as neo-adjuvant therapy pretransplantation in patients with hepatocellular carcinoma. LIVER INTERNATIONAL , 33 (6) pp. 944-949. 10.1111/liv.12144.

Tsochatzis, E; Meyer, T; O'Beirne, J; Burroughs, AK; (2013) Transarterial chemoembolisation is not superior to embolisation alone: The recent European Association for the Study of the Liver (EASL)-European Organisation for Research and Treatment of Cancer (EORTC) guidelines. EUROPEAN JOURNAL OF CANCER , 49 (6) pp. 1509-1510. 10.1016/j.ejca.2012.11.012.

Tsochatzis, E; Wijewantha, HS; Rodriguez-Peralvarez, M; Manousou, P; Fatourou, E; Giulia, P; Papastergiou, V; ... Burroughs, AK; + view all (2013) Inflammatory-based panels of markers do not predict post-translpant recurrence of hepatocellular carcinoma (HCC) in patients within Milan criteria. In: (Proceedings) 64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases. (pp. 1249A-1250A). WILEY-BLACKWELL

Tsochatzis, EA; Meyer, T; O'Beirne, J; Burroughs, AK; (2013) Transarterial therapies for hepatocellular carcinoma (HCC): A long way towards standardization. JOURNAL OF HEPATOLOGY , 58 (1) p. 194. 10.1016/j.jhep.2012.08.028.

Twelves, CJ; Wilkins, DK; Anthoney, A; Chappell, J; Ng, WT; Turner, PT; Kristeleit, R; (2013) P06.06 * EFFECTS OF TASISULAM SODIUM ON THE PHARMACOKINETICS OF TOLBUTAMIDE IN PATIENTS WITH ADVANCED SOLID TUMOURS. Annals of Oncology , 24 (suppl 1) i34-i34. 10.1093/annonc/mdt048.5.

V

Venugopal, B; Baird, R; Kristeleit, RS; Plummer, R; Cowan, R; Stewart, A; Fourneau, N; ... Banerji, U; + view all (2013) A Phase I Study of Quisinostat (JNJ-26481585), an Oral Hydroxamate Histone Deacetylase Inhibitor with Evidence of Target Modulation and Antitumor Activity, in Patients with Advanced Solid Tumors. CLINICAL CANCER RESEARCH , 19 (15) pp. 4262-4272. 10.1158/1078-0432.CCR-13-0312.

Vladimirou, E; Mchedlishvili, N; Gasic, I; Armond, JW; Samora, CP; Meraldi, P; McAinsh, AD; (2013) Nonautonomous Movement of Chromosomes in Mitosis. DEVELOPMENTAL CELL , 27 (1) pp. 60-71. 10.1016/j.devcel.2013.08.004.

W

Wason, J; Stallard, N; Dunn, J; Stein, R; (2013) An adaptive biomarker strategy clinical trial design. In: (pp. O103-O103).

Weatherstone, K; Childs, A; Meyer, T; (2013) Hepatic Tumors: An Oncologist's Perspective. pp. 273-282. 10.1002/9781118555651.ch25.

Wetterskog, D; Wilkerson, PM; Rodrigues, DN; Lambros, MB; Fritchie, K; Andersson, MK; Natrajan, R; ... Reis-Filho, JS; + view all (2013) Mutation profiling of adenoid cystic carcinomas from multiple anatomical sites identifies mutations in the RAS pathway, but no KIT mutations. HISTOPATHOLOGY , 62 (4) pp. 543-550. 10.1111/his.12050.

Wieffer, M; Uhalte, EC; Posor, Y; Otten, C; Branz, K; Schuetz, I; Moessinger, J; ... Haucke, V; + view all (2013) PI4K2 beta/AP-1-Based TGN-Endosomal Sorting Regulates Wnt Signaling. CURRENT BIOLOGY , 23 (21) pp. 2185-2190. 10.1016/j.cub.2013.09.017.

Wilson, GA; Lechner, M; Köferle, A; Carén, H; Butcher, LM; Feber, A; Fenton, T; ... Beck, S; + view all (2013) Integrated virus-host methylome analysis in head and neck squamous cell carcinoma. Epigenetics , 8 (9) pp. 953-961. 10.4161/epi.25614. Green open access
file

Wu, J; Clingen, PH; Spanswick, VJ; Mellinas-Gomez, M; Meyer, T; Puzanov, I; Jodrell, D; ... Hartley, JA; + view all (2013) gamma-H2AX Foci Formation as a Pharmacodynamic Marker of DNA Damage Produced by DNA Cross-Linking Agents: Results from 2 Phase I Clinical Trials of SJG-136 (SG2000). CLINICAL CANCER RESEARCH , 19 (3) pp. 721-730. 10.1158/1078-0432.CCR-12-2529.

Y

Yap, TA; Arkenau, H-T; Camidge, DR; George, S; Serkova, NJ; Gwyther, SJ; Spratlin, JL; ... Scurr, M; + view all (2013) First-in-Human Phase I Trial of Two Schedules of OSI-930, a Novel Multikinase Inhibitor, Incorporating Translational Proof-of-Mechanism Studies. CLINICAL CANCER RESEARCH , 19 (4) pp. 909-919. 10.1158/1078-0432.CCR-12-2258.

Yellon, DM; Boi-Doku, C; Subrayan, S; Sivaraman, V; Das, D; Vicencio, JM; Davidson, SM; (2013) RAT PLASMA EXOSOMES ARE CARDIOPROTECTIVE. In: (Proceedings) Annual Conference of the British-Cardiovascular-Society (BCS). (pp. A127-A127). BMJ PUBLISHING GROUP

This list was generated on Sun Aug 25 04:45:41 2019 BST.